Skip to content
Search

Latest Stories

Submit Guest Post

Government moves to end cancer postcode lottery

The plan will also introduce new national standards for cancer care and expand the use of cancer detection technology and artificial intelligence to support earlier diagnosis.

cancer specialists

The government will work with the Royal Colleges to encourage more doctors to train in clinical and medical oncology.

Representational image: iStock

THE GOVERNMENT will increase the number of cancer specialists in rural and coastal areas as part of plans to end the postcode lottery in cancer care across England.

New training places will be targeted at NHS trusts with the biggest workforce gaps, with a focus on areas where patients currently face longer waits to see cancer specialists. The measures will be set out in the forthcoming National Cancer Plan.


The government will work with the Royal Colleges to encourage more doctors to train in clinical and medical oncology. The plan will also introduce new national standards for cancer care and expand the use of cancer detection technology and artificial intelligence to support earlier diagnosis.

Health and Social Care Secretary Wes Streeting said: “For too long, your chances of seeing a doctor and catching cancer early have depended on where you live. That’s not fair and has to stop.”

He added: “We’re training more doctors in the communities that need them most and making sure the latest cancer detection technology reaches every corner of the country.”

Professor Peter Johnson, National Clinical Director for Cancer at NHS England, said: “We are tackling the differences in cancer care between different parts of the country head-on with the new National Cancer Plan, so that no one needing a diagnosis or treatment is left behind.”

From April 2027, new cancer tests, devices and digital tools will go through the same approval process as medicines. Once approved, the NHS will be required to fund them.

The first technologies to be assessed include a sponge test for oesophageal cancer, software to analyse tissue samples for prostate and breast cancer, artificial intelligence to read chest X-rays for suspected lung cancer, and techniques to support faster diagnosis of endometrial cancer.

Professor Jonathan Benger, Chief Executive of NICE, said: “These reforms mean that clinically and cost-effective medical devices, diagnostics and digital tools will start to be reimbursed and made available consistently across the NHS.”

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Professor Tej Lalvani, Group Chief Executive Officer, Vitabiotics

Professor Tej Lalvani, Group Chief Executive Officer, Vitabiotics

Company handout

Bain Capital to acquire UK's largest vitamin maker Vitabiotics

  • Bain Capital has agreed to acquire Vitabiotics, the UK's largest vitamin company.
  • The business will continue operating from the UK with no immediate changes to day-to-day operations.
  • The investment will focus on international expansion, digital capabilities and new product development.

Bain Capital has agreed to acquire Vitabiotics, the UK's largest vitamin company, marking the end of more than five decades of family ownership and setting the stage for the health supplements maker's next phase of international expansion.

Financial terms of the deal were not disclosed.

Keep ReadingShow less